Advertisements


Allergan"s Filings for Abicipar Pegol Accepted in U.S/Europe

Allergan plc AGN and partner M.....»»

Category: futuresSource: nasdaqSep 11th, 2019

Allergan, Molecular Partners present data from Phase 3 Abicipar pegol studies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 13th, 2019

Allergan, Molecular Partners announce FDA accepts BLA for Abicipar pegol

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: worldSource: nytSep 9th, 2019

Abbvie"s deal for Allergan clears U.S. antitrust hurdle

The deal for AbbVie Inc. to buy Allergan Plc. has cleared an antitrust hurdle, the companies said late Tuesday. The U.S. Federal Trade Commission has accepted a proposed consent order in connection with the pending acquisition, satisfying "all.....»»

Category: topSource: marketwatchMay 5th, 2020

Why This Hairy Cell Leukemia Treatment Could Be Big in Europe

Innate Pharma shares jumped on Thursday after the firm announced that the European Medicines Agency has accepted the Marketing Authorization Application for Lumoxiti for adult patients with relapsed........»»

Category: blogSource: 247wallstJan 2nd, 2020

The Daily Biotech Pulse: Canadian Approval For Amarin"s Vascepa, Innate Pharma"s Blood Cancer Drug Accepted For Review In Europe

The following is a roundup of top developments in the biotech space over the last 24 hours.  Scaling The Peaks (Biotech stocks that hit 52-week highs on Dec. 31.) 0 read more.....»»

Category: blogSource: benzingaJan 2nd, 2020

Macron Denies Accepting Putin"s Missile Moratorium For Europe: "Absolutely Not Accepted"

Macron Denies Accepting Putin's Missile Moratorium For Europe: "Absolutely Not Accepted" On Thursday contradictory messages were reported out of Europe and Russia af.....»»

Category: blogSource: zerohedgeNov 28th, 2019

Stifel says abicipar improvement not enough to make Allergan drug competitive

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 2nd, 2019

Allergan, Molecular Partners announce results from MAPLE study of abicipar

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 2nd, 2019

Europe Markets: European markets mixed as investors wait for vote on revised Brexit deal

European markets were mixed on Tuesday, as investors wait for U.K. Prime Minister Theresa May’s revised Brexit deal to be accepted or rejected by parliament.....»»

Category: topSource: marketwatchMar 12th, 2019

Esmya Restriction In Europe Could Handcuff Allergan

Esmya Restriction In Europe Could Handcuff Allergan.....»»

Category: topSource: seekingalphaMay 21st, 2018

Immigration in Europe: Helping Undocumented Immigrants Could Soon Get Hungarians a Year in Prison

"The whole of Europe has been disrupted by the refugee crisis. Unscrupulous leaders have exploited it even in countries that have accepted hardly any refugees.".....»»

Category: topSource: newsweekJun 19th, 2018

Allergan and Molecular Partners report "positive" Phase 3 results for Abicipar

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 19th, 2018

Allergan (AGN) Abicipar SEQUOIA & CEDAR Phase 3 Study Results - Slideshow

Allergan (AGN) Abicipar SEQUOIA & CEDAR Phase 3 Study Results - Slideshow.....»»

Category: topSource: seekingalphaJul 19th, 2018

Allergan"s Big Win For 12-Week Wet AMD Dosing With Abicipar May Be Enough To Pit It Against A Host Of Competitors

Allergan"s Big Win For 12-Week Wet AMD Dosing With Abicipar May Be Enough To Pit It Against A Host Of Competitors.....»»

Category: topSource: seekingalphaJul 20th, 2018

Allergan: Inflammation Is The Reason Investors Did Not React Well To Abicipar Results

Allergan: Inflammation Is The Reason Investors Did Not React Well To Abicipar Results.....»»

Category: topSource: seekingalphaJul 23rd, 2018

Allergan stops sales in Europe of breast implants linked to cancer

The decision concerned Allergan's Microcell and Biocell products......»»

Category: topSource: foxnewsDec 19th, 2018

Europe Just Banned Allergan Breast Implants. Here’s Why

France has advised patients with textured implants to undergo regular checks for a blood cancer called anaplastic large cell lymphoma (ALCL) France’s national health regulator refused to renew approval Tuesday for two types of Allerg.....»»

Category: europeSource: fortuneDec 19th, 2018

Allergan"s stock falls toward 5-year low after suspending sales of textured breast implants in Europe

Shares of Allergan PLC sank 3.4% toward a 5-year low in premarket trade Wednesday, after the biopharmaceutical company said it has suspended sales to textured breast implants in Europe, and will withdraw all remaining supply, falling a "compu.....»»

Category: topSource: marketwatchDec 19th, 2018

Breast implants recalled: Allergan ends sales of 'textured' implants in Europe

Biopharmaceutical company Allergan is recalling rough-surface breast implants in Europe. But the company says it's not recommending surgical re.....»»

Category: topSource: usatodayDec 19th, 2018

Allergan Drops, Stops Textured Breast Implant Sales in Europe

Allergan (AGN) halts the sale of its textured breast implants and tissue expanders i.....»»

Category: smallbizSource: nytDec 20th, 2018